taspine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Sarwar, A; Su, Q; Wang, J; Wu, Q; Zhang, Y | 1 |
| Chen, Y; He, L; Liu, C; Smith, WW; Wang, N; Zhan, Y; Zhang, J; Zhang, Y; Zheng, L | 1 |
2 other study(ies) available for taspine and Breast Cancer
| Article | Year |
|---|---|
Induction of estrogen receptor β-mediated autophagy sensitizes breast cancer cells to TAD1822-7, a novel biphenyl urea taspine derivative.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Autophagy; Biphenyl Compounds; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor beta; Female; Humans; Morpholines; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Urea | 2022 |
A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Topics: Acetanilides; Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2012 |